To include your compound in the COVID-19 Resource Center, submit it here.

Motolimod regulatory update

VentiRx said FDA granted Fast Track designation for motolimod in combination with pegylated liposomal doxorubicin

Read the full 151 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE